Potential new imaging agent in diagnosis, monitoring of prostate cancer

About 19 months ago we reported that a company called Progenics Pharmaceuticals had acquired all rights to a small, radiolabeled molecule known as [99mTc]MIP-1404, and that an international, multi-center Phase II trial was  investigating the clinical activity of [99mTc]MIP-1404 as a prostate cancer imaging agent. … READ MORE …

7-T MRIs in the diagnosis and work-up of localized prostate cancer

References to 1.5-T, 3-T, and 7-T MRI machines are based on the size and power of the magnets used in the creation of MRI images by the machines. The T stands for “tesla”. It is a measure of magnetic flux density, and one tesla (1 T) is equal to one weber per square metre (1 Wb/m2). … READ MORE …

Potential new imaging test for metastatic prostate cancer

According to a newly published study in the journal Cancer Research, a collaborative research team at the Massey Cancer Center of Virgina Commonwealth University and at Johns Hopkins has developed a new, systemically administered, non-invasive, molecular-genetic technique to image bone metastases resulting from prostate cancer. … READ MORE …

Current and future imaging techniques and recurrent prostate cancer

An article just reproduced on the Medscape Oncology web site provides a very readable review of what the authors describe as, “A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer”. … READ MORE …

Newer radio-tracer shows potential in imaging of recurrent prostate cancer

Data have been emerging for a while to suggest that a new imaging agent known as anti-3-[18F]FACBC (when used in PET/CT scans may be better than [11C]choline in the identification of recurrent (or primary) cancers on PET/CT scans or than older agents like [111In]capromab pendetide (Prostascint) when used in SPECT/CT scans. … READ MORE …

Use of imaging tests in low-risk prostate cancer — striking the right balance

An article published a couple of weeks ago in the Journal of the National Cancer Institute looks at the effects of a physician education campaign in Sweden to reduce the inappropriate use of bone scans and other imaging tests among men with an initial diagnosis of low-risk prostate cancer. … READ MORE …

“Multispectral photoacoustic imaging” for risk of prostate cancer

According to a media release issued earlier today by the University of Rochester Medical Center, “A new imaging technology that combines ultrasound and laser technologies has been shown to be highly effective in identifying prostate cancer.” … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,185 other followers